Much is invested to bring premature infants to the point of hospital discharge. However, there is an extreme drop-off in services after the infant is released from the hospital. This is a very important area for preventative healthcares and should be conceptualized as a chronic condition says our guest, Dr. Heidi Feldman, professor of developmental and behavioral medicine at Stanford University School of Medicine Lucile Packard Children's Hospital. She and host Dr. Bill Rutenberg discuss interventions often required to help a pre-mature infant to reach its developmental age. How much intervention is necessary? Do socioeconomics play a role in which children are most likely to catch up sooner? Why do kids who get the most services often have the greatest delay? Join us to learn more.
Preemies: Post-Discharge Developmental Catch-Up
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Much is invested to bring premature infants to the point of hospital discharge. However, there is an extreme drop-off in services after the infant is released from the hospital. This is a very important area for preventative healthcares and should be conceptualized as a chronic condition says our guest, Dr. Heidi Feldman, professor of developmental and behavioral medicine at Stanford University School of Medicine Lucile Packard Children's Hospital. She and host Dr. Bill Rutenberg discuss interventions often required to help a pre-mature infant to reach its developmental age. How much intervention is necessary? Do socioeconomics play a role in which children are most likely to catch up sooner? Why do kids who get the most services often have the greatest delay? Join us to learn more.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
Level Up Your Skills: Tailoring Management of HF
Impact of Barostim on Heart Failure Hospitalization
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?